Related Experiment Video
Updated: Mar 23, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity
Ying Kai Chan1, Michaela U Gack1,2
1Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
14-3-3 proteins regulate biological processes by binding to phosphorylated serine or phosphorylated threonine motifs of cellular proteins. Among the 14-3-3 proteins, 14-3-3ɛ serves a crucial function in antiviral immunity by mediating the cytosol-to-mitochondrial membrane translocation of the pathogen sensor RIG-I. Here we found that the NS3 protein of dengue virus (DV) bound to 14-3-3ɛ and prevented translocation of RIG-I to the adaptor MAVS and thereby blocked antiviral signaling. Intriguingly, a highly conserved phosphomimetic RxEP motif in NS3 was essential for the binding of 14-3-3ɛ. A recombinant mutant DV deficient in binding to 14-3-3ɛ showed impairment in antagonism of RIG-I and elicited a markedly augmented innate immune response and enhanced T cell activation. Our work reveals a novel phosphomimetic-based mechanism for viral antagonism of 14-3-3-mediated immunity, which might guide the rational design of therapeutics.
Insights
Dengue virus NS3 protein targets 14-3-3 epsilon (14-3-3ɛ) via a phosphomimetic motif, blocking RIG-I antiviral signaling. This interaction impairs innate immunity, offering therapeutic targets.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- 14-3-3 proteins are crucial regulators of cellular processes, including immune responses.
- 14-3-3 epsilon (14-3-3ɛ) is vital for antiviral immunity, facilitating RIG-I translocation.
- RIG-I (Retinoic acid-inducible gene I) is a key pathogen sensor in innate immunity.
Purpose of the Study:
- To investigate the mechanism by which dengue virus (DV) antagonizes host antiviral immunity.
- To identify viral factors and host proteins involved in DV immune evasion.
- To explore the role of the 14-3-3ɛ protein in DV infection.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions between DV NS3 and 14-3-3ɛ.
- Analysis of RIG-I translocation using cell-based assays.
- Generation and characterization of a recombinant DV mutant lacking the 14-3-3ɛ binding motif.
- Assessment of innate immune responses and T cell activation in infected hosts.
Main Results:
- The dengue virus NS3 protein directly binds to 14-3-3ɛ.
- A conserved phosphomimetic RxEP motif in NS3 is essential for 14-3-3ɛ binding.
- DV NS3 binding to 14-3-3ɛ inhibits RIG-I translocation to MAVS, blocking antiviral signaling.
- A recombinant DV mutant unable to bind 14-3-3ɛ exhibits impaired antagonism of RIG-I and elicits a stronger innate immune response.
Conclusions:
- Dengue virus employs a novel mechanism of antagonism by hijacking 14-3-3ɛ via a phosphomimetic motif in NS3.
- This interaction disrupts RIG-I-mediated antiviral signaling, contributing to viral immune evasion.
- Understanding this interaction provides insights for developing therapeutics targeting viral antagonism of host immunity.
More Related Videos
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Diphtheria
Viruses with RNA Genomes
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...